Viewing Study NCT00463203

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 7:24 PM
Ignite Modification Date: 2025-12-30 @ 12:37 PM
Study NCT ID: NCT00463203
Status: COMPLETED
Last Update Posted: 2011-06-29
First Post: 2007-04-18
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Bevacizumab and Irinotecan for Patients With Primary Brain Tumors and Progression After Standard Therapy
Sponsor: Rigshospitalet, Denmark
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Brain Neoplasms View
None Glioma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None primary malignant brain tumor View
None grade II glioma View
None meningeoma View
None ependymoma View
None Recurrence or progression after standard treatment View